Remove Ethics Remove Leadership Remove Price Remove Venture Capitalist
article thumbnail

Calculating the Market Value of Leadership

Harvard Business Review

We believe that a next step for investors is to analyze the predictors and drivers of these intangible factors, which means focusing on leadership. Wise, long term investors recognize that leadership affects firm performance. But too often, assessments of leadership are haphazard and narrow.

article thumbnail

Are Your Most Talented People Losing Their Minds?

Harvard Business Review

If determining whether your employees are losing their ability to effectively process ideas and information costs next to nothing , aren't you ethically obligated to find that out? If you seek premium prices from customers and clients for your knowledge-intensive services, they may insist they do. Are you ready to take your test?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

“Trust Me, I’m a Leader”: Why Building a Culture of Trust Will Boost Employee Performance – and Maybe Even Save Your Company

Strategy Driven

Unusually Excellent: The Necessary Nine Skills Required for the Practice of Great Leadership by John Hamm. Unusually Excellent is a back-to-basics reference book that offers both seasoned and aspiring leaders a framework for understanding and a guide for applying the battle-tested fundamentals of leadership at every stage of their careers.

Company 62
article thumbnail

“Trust Me, I’m a Leader”: Why Building a Culture of Trust Will Boost Employee Performance – and Maybe Even Save Your Company

Strategy Driven

Unusually Excellent: The Necessary Nine Skills Required for the Practice of Great Leadership by John Hamm. Unusually Excellent is a back-to-basics reference book that offers both seasoned and aspiring leaders a framework for understanding and a guide for applying the battle-tested fundamentals of leadership at every stage of their careers.

Company 50
article thumbnail

How Merck Is Trying to Keep Disrupters at Bay

Harvard Business Review

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. Experimentation is vital.